Vyriad
Vyriad is a United States-based biotechnology company running 2 late-stage cancer trials in melanoma, head and neck squamous cell carcinoma and colorectal cancer.
Overview
Vyriad, based in Rochester, the United States, is a biotechnology company. Vyriad engineers targeted viral platforms for genetic therapies, developing in vivo gene therapies, genome editing and oncolytic virotherapies delivered through engineered virus vectors, including VSV and measles virus platforms. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials in melanoma, head and neck squamous cell carcinoma, colorectal cancer, non-small-cell lung cancer and neuroendocrine tumours. The largest, NCT04291105 (Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients), plans to enrol 87 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Similar pages
not linked directly; found by shared links- CompanyMultitude Therapeutics
Shares Melanoma, Colorectal cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyScancell
Shares Renal cell carcinoma, Head and neck squamous cell carcinoma, Melanoma and the tag ctgov-sponsor.
- CompanyKrystal Biotech
Shares Melanoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanymAbxience Research S.L.
Shares Melanoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanySTCube
Shares Colorectal cancer, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyOncoC4
Shares Renal cell carcinoma, Head and neck squamous cell carcinoma, Melanoma, Colorectal cancer and the tag ctgov-sponsor.
- CompanyTiumBio
Shares Head and neck squamous cell carcinoma, Colorectal cancer and the tag ctgov-sponsor.
- CompanyAP Biosciences
Shares Head and neck squamous cell carcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.